CSS
ACIU icon

Cubist Systematic Strategies’s AC Immune ACIU Stock Holding History

Cubist Systematic Strategies’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,667
Closed -$31.5K – 2797
2024
Q4 		$31.5K Sell
11,667
-2,604
-18% -$8.14K ﹤0.01% 2820
2024
Q3 		$53.9K Sell
14,271
-40,339
-74% -$141K ﹤0.01% 2757
2024
Q2 		$218K Buy
+54,610
New +$181K ﹤0.01% 2480
2023
Q1 		– Sell
-21,384
Closed -$43.6K – 3844
2022
Q4 		$43.6K Buy
+21,384
New +$55.1K ﹤0.01% 3920
2022
Q1 		– Sell
-15,327
Closed -$76K – 3525
2021
Q4 		$76K Sell
15,327
-26,992
-64% -$157K ﹤0.01% 3252
2021
Q3 		$284K Buy
42,319
+35,873
+557% +$257K ﹤0.01% 2386
2021
Q2 		$51K Buy
+6,446
New +$44.5K ﹤0.01% 2789
2019
Q3 		– Sell
-10,397
Closed -$58K – 2182
2019
Q2 		$58K Buy
+10,397
New +$53K ﹤0.01% 2303
2016
Q4 		– Sell
-11,222
Closed -$185K – 1687
2016
Q3 		$185K Buy
+11,222
New +$194K 0.01% 1286

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cubist Systematic Strategies's ACIU Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of AC Immune (ACIU) in Q1 2025, closing a stake of 11,667 shares — an estimated $31.5K sold.

Cubist Systematic Strategies first reported a position in ACIU in Q3 2016 and held it in 9 quarters. The position peaked at $284K in Q3 2021. 41 funds tracked by Wall St. Rank hold ACIU as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining AC Immune position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 11,667 AC Immune shares in Q1 2025, an estimated $31.5K.
  • Cubist Systematic Strategies first reported a position in AC Immune in Q3 2016 and held it in 9 quarters.
  • Cubist Systematic Strategies's AC Immune position peaked at $284K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held AC Immune as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.